SC lets Salve withdraw as amicus, adjourns hearing on Covid-19 cases

Bench says it has not stopped High Courts from hearing cases related to how the state is managing the pandemic.

Covid
Health workers at a makeshift quarantine center set up in a banquet hall in New Delhi, on April 21. India's woefully inadequate hospital infrastructure is collapsing as daily new cases reach almost 300,000 this week. Photographer: Anindito Mukherjee
PTI New Delhi
2 min read Last Updated : Apr 23 2021 | 1:16 PM IST
The Supreme Court Friday allowed senior advocate Harish Salve to withdraw as amicus curiae for the suo motu case related to distribution of essential supplies and services, including oxygen and drugs, during the COVID-19 pandemic.

A bench headed by Chief Justice S A Bobde, who is demitting office as the CJI Friday itself, rapped some senior advocates for making statements without reading its order passed on Thursday and observed that it did not stop high courts from hearing cases related to COVID-19 management in the country.

The bench, also comprising Justices L N Rao and S R Bhat, granted time to the Centre to file response in the case and posted it for hearing on April 27.

“You have imputed motives to us without reading our order,” the bench told senior advocate Dushyant Dave, who was appearing in the matter.

“We are also pained at reading what some senior lawyers have to say on Salve''s appointment as amicus in the matter,” the bench said, adding that it was a "collective decision" of all the judges at the bench.

Salve said it is a “very sensitive” matter and he did not want the case to be decided under the shadow that he knew the CJI from school and college days.

Solicitor General Tushar Mehta requested Salve not to withdraw from the case as the amicus on the ground that no one should succumb to such pressure tactics.

Taking note of the “grim” situation created by the massive surge in COVID-19 cases and deaths, the Supreme Court had on Thursday said it expects the Centre to come out with a “national plan” to deal with proper distribution of oxygen and essential drugs for the patients. 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusSupreme CourtJustice SA Bobde

Next Story